Results 21 to 30 of about 22,634 (197)
Asia-Pacific Journal of Ophthalmology, 2017 Retinal vein occlusions are a very common condition with great importance in ophthalmology clinical practice. This article reviews the salient epidemiology, risk factors, clinical features, and treatments related to retinal vein occlusions.
Michael, Ip, Andrew, Hendrick
openaire +2 more sources
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Advanced Robotics Research, EarlyView.Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source
Advanced Science, EarlyView.Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
F1000Research, 2018 Retinal vein occlusions are the second most common form of retinal vascular disease. Previously, laser treatment for branch retinal vein occlusion and intravitreal triamcinolone acetonide for central retinal vein occlusion were the standard of care ...
Daniel D. Esmaili, David S. Boyer
doaj +1 more source
Retinal vascular occlusion in patients with the Covid-19 virus
International Journal of Retina and Vitreous, 2022 Background The coronavirus disease (COVID-19) can cause acute respiratory distress syndrome with dyspnea, anosmia, fever, and cough. Few studies describing ocular findings have been reported.
Helio F. Shiroma +7 more
doaj +1 more source
Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma
Advanced Science, EarlyView.This review evaluates nanoparticle‐based phototherapies for uveal melanoma, highlighting emerging strategies to enhance tumor targeting, light delivery, and treatment precision. Preclinical data indicate improved efficacy and reduced toxicity, supporting their potential to enhance localized treatment and future translational advances. (Generated by the
Emilie Lambert +8 more
wiley +1 more source
Self‐Propelled HPB@Lip@AB Nanomotors Ameliorate Dry Eye Disease
Advanced Science, EarlyView.A self‐propelled HPB@Lip@AB nanomotor system is developed for dry eye disease (DED) therapy, facilitating rapid penetration across ocular surface barriers while integrating hydrogen therapy with multi‐enzyme‐like antioxidant activity. The nanoplatform restores mitochondrial function, suppresses oxidative stress, inflammation, and apoptosis, and ...
Jing Li +9 more
wiley +1 more source
BILATERAL SIMULTANEOUS CENTRAL RETINAL VEIN OCCLUSION IN A PATIENT WITH SYSTEMIC HYPERTENSION
Journal of University Medical & Dental College, 2020 The central retinal vein occlusion is caused by age related changes in the retinal vessels. Bilateral central retinal vein occlusion is a relatively rare event. Only less than 10% cases are bilateral.
Basim Mubarik, Aamir Ali Choudhry
doaj
The new complex method of treatment central retinal veinand branch of retinal vein occlusion
Бюллетень сибирской медицины, 2008 The new treatment method of central retinal vein and branch of retinal vein occlusion, consisting of epiretinal injection of gemasa combined with standard pharmacotherapy was developed.
D. V. Petrachkov
doaj +1 more source
Case Reports in Ophthalmology, 2022 We describe the clinical features and treatment outcome of a patient with combined central retinal vein occlusion and cilioretinal artery occlusion. A 52-year-old female presented to our clinic with decreased vision in the right eye for 4 days.
Alemu Kerie Tesfaw +2 more
doaj +1 more source